DARPA has artificial blood; Cullen family stock upgraded to 'buy'

Trent Wolbe
T. Wolbe|07.14.10

Sponsored Links

Trent Wolbe
July 14th, 2010
DARPA has artificial blood; Cullen family stock upgraded to 'buy'
A few years ago, DARPA teamed up with a company called Arteriocyte to research methods for manufacturing blood without an actual donor on-hand, and whaddya know -- a million and change tax dollars later, here we are. You no doubt remember stem cells. Well, they're back in a major way (did they really ever leave?), and this time instead of clogging up the Supreme Court's backlog they're helping manufacture blood that is "functionally indistinguishable" from the real type-O. "Pharmed" blood (their word, not ours) will eventually be a godsend for troops in the field, where fresh blood often takes three weeks to arrive from the source. But don't cancel all your donor appointments just yet -- eBlood (our word, not theirs) won't be ready for human testing until 2013. And pints still cost more than a bottle of Johnny Walker's finest -- around $5,000, and that's before they factor in the cookies and apple juice they gave the umbilical cord for its time and patience.
All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
Popular on Engadget